ATE60359T1 - Menschlicher b-zellen-differenzierungsfaktor und verfahren zu dessen herstellung. - Google Patents

Menschlicher b-zellen-differenzierungsfaktor und verfahren zu dessen herstellung.

Info

Publication number
ATE60359T1
ATE60359T1 AT87113774T AT87113774T ATE60359T1 AT E60359 T1 ATE60359 T1 AT E60359T1 AT 87113774 T AT87113774 T AT 87113774T AT 87113774 T AT87113774 T AT 87113774T AT E60359 T1 ATE60359 T1 AT E60359T1
Authority
AT
Austria
Prior art keywords
cell differentiation
differentiation factor
human
production
methods
Prior art date
Application number
AT87113774T
Other languages
English (en)
Inventor
Tasuku Honjo
Kiyoshi Takatu
Eva Severinson
F Building
Original Assignee
Tasuku Honjo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tasuku Honjo filed Critical Tasuku Honjo
Application granted granted Critical
Publication of ATE60359T1 publication Critical patent/ATE60359T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5409—IL-5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT87113774T 1986-09-20 1987-09-21 Menschlicher b-zellen-differenzierungsfaktor und verfahren zu dessen herstellung. ATE60359T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP22328486 1986-09-20
EP87113774A EP0261625B1 (de) 1986-09-20 1987-09-21 Menschlicher B-Zellen-Differenzierungsfaktor und Verfahren zu dessen Herstellung

Publications (1)

Publication Number Publication Date
ATE60359T1 true ATE60359T1 (de) 1991-02-15

Family

ID=16795717

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87113774T ATE60359T1 (de) 1986-09-20 1987-09-21 Menschlicher b-zellen-differenzierungsfaktor und verfahren zu dessen herstellung.

Country Status (8)

Country Link
US (2) US5324640A (de)
EP (1) EP0261625B1 (de)
JP (1) JP2642103B2 (de)
AT (1) ATE60359T1 (de)
AU (1) AU604055B2 (de)
CA (1) CA1340689C (de)
DE (1) DE3767629D1 (de)
ES (1) ES2039390T3 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3750106T3 (de) * 1986-08-06 1999-04-22 Ajinomoto Co., Inc., Tokio/Tokyo Rekombinanter B-Zell-Differenzierungsfaktor.
ES2039390T3 (es) * 1986-09-20 1993-10-01 Tasuku Honjo Un procedimiento para producir un factor de diferenciacion de celulas b humanas.
EP0267779A3 (de) * 1986-11-10 1990-01-17 Schering Biotech Corporation Menschlicher pleitroper Immunfaktor und dessen Muteine
JPH0331215A (ja) * 1989-06-27 1991-02-12 Ajinomoto Co Inc 制癌療法支持剤
EP0557420A1 (de) * 1990-11-16 1993-09-01 Schering Corporation Methode um die differenzierung von myeloblasten mit interleukin-5 zu induzieren
JPH0775593A (ja) * 1993-09-08 1995-03-20 Suntory Ltd 蛋白質の製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987004466A1 (en) * 1986-01-15 1987-07-30 Amersham International Plc Interleukin
DE3750106T3 (de) * 1986-08-06 1999-04-22 Ajinomoto Co., Inc., Tokio/Tokyo Rekombinanter B-Zell-Differenzierungsfaktor.
ES2039390T3 (es) * 1986-09-20 1993-10-01 Tasuku Honjo Un procedimiento para producir un factor de diferenciacion de celulas b humanas.
JPS63146798A (ja) * 1986-11-10 1988-06-18 シェリング・バイオテック・コーポレーション ヒト多機能性免疫因子及びその突然変異タンパク
JP2805224B2 (ja) * 1989-01-13 1998-09-30 味の素株式会社 血小板減少症治療剤

Also Published As

Publication number Publication date
AU7880987A (en) 1988-05-19
US5530098A (en) 1996-06-25
CA1340689C (en) 1999-08-03
EP0261625A2 (de) 1988-03-30
JP2642103B2 (ja) 1997-08-20
DE3767629D1 (de) 1991-02-28
US5324640A (en) 1994-06-28
JPS63185387A (ja) 1988-07-30
ES2039390T3 (es) 1993-10-01
EP0261625B1 (de) 1991-01-23
AU604055B2 (en) 1990-12-06
EP0261625A3 (en) 1988-10-26

Similar Documents

Publication Publication Date Title
DE69333346D1 (de) Neuartiges p- selectin ligandenprotein
ATE149524T1 (de) Dns, die ein menschliches, gefässverengendes peptid kodiert, und dessen verwendung
DE3587422D1 (de) Fuer ein hirudinaehnliches protein kodierende dns-sequenz und verfahren zur herstellung eines solchen proteins.
DE69636728D1 (de) Neues protein und verfahren zu dessen herstellung
CA2263889A1 (en) P-selectin ligand proteins
ATE26463T1 (de) Verfahren zur herstellung von menschlichem leukozyten-interferon.
DE3669175D1 (de) Fusionsproteine, verfahren zu ihrer herstellung und ihre verwendung.
DE3855122D1 (de) Artifizielles Gen, das für humane Serumalbumine kodiert, seine Verwendung und Verfahren zu seiner Herstellung
ES8603574A1 (es) "procedimiento de tecnologia genetica para preparar secuen- cias parciales del gamma-interferon de humano".
FI90667C (fi) Menetelmä valmistaa uutta ihmisen tyypin I interferoniproteiinia
ATE124454T1 (de) Gentechnische herstellung von faktor xiiia.
WO1995030001A3 (en) Novel p-selectin ligand protein
ATE60359T1 (de) Menschlicher b-zellen-differenzierungsfaktor und verfahren zu dessen herstellung.
DE3854420D1 (de) Onkogen kodierendes polypeptid, das wachstumsfaktoraktivität besitzt, verfahren zu seiner herstellung und verwendung.
PL309882A1 (en) Dna sequence encoding novel biosynthetic insulin precursors and insulin obtaining method
DE3750348D1 (de) Verfahren zur Herstellung von Peptiden, dazu zu verwendendes rekombinantes Plasmid und mit diesem Plasmid transformierte Myelomzellen.
ES2115208T3 (es) Proteina de la superficie celular de brevibacterium lactofermentum.
ATE145939T1 (de) Mitogen für die glatte muskulatur und dessen kodierende dns
DE148922T1 (de) Hybride dns-synthese des epidermwachstumsfaktors.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time